Clinical Trial Update: A Study to Treat Subjects With Telaprevir, Ribavirin, and Peginterferon Who Are Coinfected With HIV and Hepatitis C Virus (HCV) [Phase 3]

View source ↗

Summary

Phase 3 study evaluating telaprevir with ribavirin and peginterferon for HIV/Hepatitis C coinfection was terminated, with results posted in March 2015.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infection
• Hepatitis C

Drugs mentioned

• Copegus (ribavirin)
• Incivek (telaprevir)
• Pegasys (pegylated interferon alfa-2a)

Snippet

Sponsor: Vertex Pharmaceuticals Incorporated | Conditions: Hepatitis C | Phase 3 | Status: TERMINATED | Results posted: 2015-03-17